Inventor · disambiguated record
Michael Lebowitz
Also filed as: LEBOWITZ MICHAEL · LEBOWITZ MICHAEL S
13 granted patents·18 pending applications·153 citations·filing 1998–2023
91Inventor score
Files withPANACEA PHARMACEUTICALS INC6ATHANOR BIOSCIENCES INC4UNIV JOHNS HOPKINS420/20 GENESYSTEMS INC320/20 GeneSystems3
Top patents by PatentIndex Score
31 records- 0195US11989019B1Systems and methods for detecting and transmitting driving condition information related to an autonomous vehicleUSAA·Filed 2020·Granted May 21, 2024·6 cites·20 claims
- 0293US11405441B1Systems and methods for data pre-fetchingUSAA·Filed 2020·Granted Aug 2, 2022·6 cites·20 claims
- 0391US6780971B2Compositions for inhibiting the aggregation pathway of α-synucleinPANACEA PHARMACEUTICALS INC·Filed 2001·Granted Aug 24, 2004·51 cites·4 claims
- 0487US6458354B1Molecular complexes which modify immune responsesUNIV JOHNS HOPKINS·Filed 2000·Granted Oct 1, 2002·28 cites·13 claims
- 0580US2023393150A1Methods and algorithms for aiding in the detection of cancer20/20 GeneSystems·Filed 2023·Application pending·0 cites
- 0679US10156575B2Methods and algorithms for aiding in the detection of cancer20/20 GENESYSTEMS INC·Filed 2017·Granted Dec 18, 2018·1 cites·14 claims
- 0776US7973137B1Cell compositions comprising molecular complexes that modify immune responsesUNIV JOHNS HOPKINS·Filed 2000·Granted Jul 5, 2011·8 cites·15 claims
- 0874US6140113APolynucleotides encoding molecular complexes which modify immune responsesUNIV JOHNS HOPKINS·Filed 1998·Granted Oct 31, 2000·45 cites·12 claims
- 0971US7605133B2Isolated peptides to treat alpha-synuclein diseasesPANACEA PHARMACEUTICALS INC·Filed 2004·Granted Oct 20, 2009·2 cites·12 claims
- 1068US11733249B2Methods and algorithms for aiding in the detection of cancer20/20 GENESYSTEMS INC·Filed 2018·Granted Aug 22, 2023·0 cites·8 claims
- 1167US11799933B1Systems and methods for data pre-fetchingUSAA·Filed 2022·Granted Oct 24, 2023·0 cites·20 claims
- 1267US7456179B2Methods of treating ischemic related conditionsPANACEA PHARMACEUTICALS INC·Filed 2004·Granted Nov 25, 2008·6 cites·1 claims
- 1360US2009155289A1Furin-cleavable peptide linkers for drug-ligand conjugatesROBERTS STEVE·Filed 2008·Application pending·0 cites
- 1458US9753043B2Methods and algorithms for aiding in the detection of cancer20/20 GENESYSTEMS INC·Filed 2012·Granted Sep 5, 2017·0 cites·22 claims
- 1557US2023346862A1Cancer eradicating - bio-nanoparticles (ce-bnp)ATHANOR BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1656US2021148915A9Recovery of aspartyl (asparaginyl) beta hydroxylase (haah) from an exosomal fraction of human sera from cancer patientsPANACEA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1754US2012141482A1Molecular complexes which modify immune responsesSCHNECK JONATHAN·Filed 2012·Application pending·0 cites
- 1854US2023223145A1Methods and software systems to optimize and personalize the frequency of cancer screening blood tests20/20 GeneSystems·Filed 2021·Application pending·0 cites
- 1953US2023050559A1Size-based detection and quantification of functional bio-nanoparticlesATHANOR BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2053US2008124718A1Methods of diagnosing, predicting therapeutic efficacy and screening for new therapeutic agents for leukemiaPANACEA PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2153US2011243967A1Molecular complexes which modify immune responsesUNIV JOHNS HOPKINS·Filed 2011·Application pending·0 cites
- 2250US2016077098A1Recovery of aspartyl (asparaginyl) beta hydroxylase (haah) from an exosomal fraction of human sera from cancer patientsSEMENUK MARK·Filed 2015·Application pending·0 cites
- 2350US2013174051A1Bundling content and functionality into data that is referenced by a tagSCHATZBERGER RICHARD·Filed 2012·Application pending·0 cites
- 2449US11826421B2Bacteriophage-based vaccines and engineered bacteriophageATHANOR BIOSCIENCES INC·Filed 2021·Granted Nov 28, 2023·0 cites·21 claims
- 2548US2021309973A1Bacteriophage-Based Antibodies and BindersATHANOR BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2647US2009298097A1Methods for the diagnosis of lung cancerHARRIS PAMELA J·Filed 2008·Application pending·0 cites
- 2746US2009275587A1Methods of treating ischemic related conditionsALMASSIAN BIJAN·Filed 2008·Application pending·0 cites
- 2844US2020390902A1Antibody-Drug Conjugates Targeted at Human Aspartyl-(Asparaginyl)-B-Hydroxylase (HAAH)PANACEA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2941US2023263477A1Universal pan cancer classifier models, machine learning systems and methods of use20/20 GeneSystems·Filed 2021·Application pending·0 cites
- 3040US2019345261A1Aspartate beta-hydroxylase chimeric antigen receptors and uses thereofSENSEI BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3130US2006194810A1Methods of treating ischemic related conditionsALMASSIAN BIJAN·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Lebowitz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →